This is why analysis of the data is important and relevant,

New Post Public Reply Private Reply Replies (0) Message Board
calstang MAV MD #80422
416
This is why analysis of the data is important and relevant, and why we could see a partial EUA (but I think not). Sponsoring drug companies of trials can propose exclusion of certain groups of covid-19 patients which would not only effect their results, but later, will also effect the assessement and approval by the scrutinizing FDA.

So when a PR says such and such reduction in death rate, the general public may react with "wow" and "amazing" and the PR author may deceptively describe the results as "wow" and "amazing", but scrutiny may reveal that the data is not actually so significant.

from suecier on YF:
It's easy to believe that we have the intelligence and technologies that are pushing discoveries on cutting edge biological advancements across the bio-tech industry and so many other sectors because it has been proven and backed by science, data and facts, yet there is so much corruption at every turn, in every industry, and most apparent, in our government and institutions, that it's seemingly difficult to understand and hard to believe we are moving at the rate we are when all things considered.

IMO much is to lay at the foot of corruption blocking advancement to control money and power. There are always skeptics and critics that try and sow doubt and fear in the minds of people with objectives that are sometimes obvious and sometimes deeply hidden to be kept secret because those in power control the money. For example, why does it take on average 10 years for a life saving drug to go to market?, is it the FDA, BP with deep pockets and power, the CDC, the SEC, the Fed or U.S. government, etc. etc. ? Yes, perhaps all and more?!?

Leronlimab's efficacy and life saving benefits are going to be disclosed soon and we will all be better off as long as NP and company can navigate and catapult through the corruption that we all know exists, which IMO he will. Also, IMHO, after many deep dives into the science and data, I believe LL is a breakthrough lifesaving drug. Most morally sound scientists I think would agree that LL has been on the shelf for way too long and the world is waiting for this discovery. Just like it has been way too long waiting for the cure for cancer?!? - We should have a cure for cancer by now considering the limitless amounts of money granted for studies and therapies to treat and cure all types of cancers...why don't we have? - greed and corruption perhaps?!?


CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MacGregor's Bold Play: RoRo Tech for TT-Line's Ferries

Updated Category News Views 1

A Green Wave in the Baltic It looks like MacGregor's betting big on the future of maritime transport, and they're putting their chips down on TT-Line's next-gen battery-hybrid LNG ferries. With a contract fresh out of the oven, they've signed up to kit out these eco-warriors with a range of RoRo equipment. And let me tell you, this is no piddly order—by any stretch,...

Continue Reading
Business Leaders Push for Justice Reform Policy

Updated Category News Views 1

Business stepping up to bat for justice reform? Yeah, that’s what's shaking over in Washington, D.C. this Constitution Day. We're seeing a gathering of senior business execs, policymakers, and public safety advocates, intent on driving judicial reform in the U.S. Usually, the suits in these rooms talk about profit margins and quarterly results, but this time they're...

Continue Reading
Fit Bodies and Hyatt Forge Landmark Wellness Alliance

Updated Category News Views 5

From Beachfront Beginnings to Global Fitness Leader Picture this: It's 1992, and Suzelle Snowden has an audacious idea. Teaching fitness classes at resorts in exchange for accommodations. Fast-forward three decades, and now, her brainchild, Fit Bodies, Inc., isn't just a wellness travel company; it's a behemoth, partnering with Hyatt's premier resorts across Mexico, the...

Continue Reading
Arlo Technologies Faces Possible Fiduciary Breach Probe

Updated Category News Views 2

Shareholder Investigation Shakes Things Up Like a surprise punch straight outta nowhere, Arlo Technologies, Inc. (NYSE: ARLO) finds itself under the magnifying glass of Levi & Korsinsky, LLP. They're sniffing around for possible breaches of fiduciary duties by ARLO's officers and directors. It’s a jolting call for shareholders, who need to stay sharp and not get caught...

Continue Reading
Immunic Pushes Boundaries in MS with Vidofludimus

Updated Category News Views 0

Shaking Things Up in Multiple Sclerosis Therapy There's no telling how often the biotech sector tosses around the term 'game-changer,' but when Immunic's name comes up, more ears are perking up these days. The New York-based firm, waving the Nasdaq: IMUX flag, is lining up a virtual shindig come September 9, 2026, and for anyone invested in multiple sclerosis (MS) or...

Continue Reading
Tolnai Joins UPCEA Leaders Pioneering Credential Innovations

Updated Category News Views 0

The Future of Education Shaped Today There's a profound shift happening in higher education, and it's not the usual undergrad grind most folks think of. Cate Tolnai, stepping into her role at the University of Phoenix, is in the thick of it. She's set to join the UPCEA Council for Credential Innovation's leadership team, and that isn't some fluff title. Her appointment...

Continue Reading
Hormel Foods Gears Up for Barclays Conference

Updated Category News Views 6

Hormel Foods Takes the Stage at Barclays When it comes to branded food, few players can command attention quite like Hormel Foods Corporation. They're set to make a splash at the upcoming 2026 Barclays Global Consumer Staples Conference. On September 9, Jeff Ettinger, interim CEO, and John Ghingo, the CEO-elect, will lead a fireside chat at 1:30 p.m. ET. They're not just...

Continue Reading
Smart Buying in Hilton Head: Second-Home Key Insights

Updated Category News Views 1

Choosing Your Slice of Paradise in Hilton Head Picture this—not just a sandy paradise for vacationing, but a hotspot for second-home buyers weighing their options like they're sizing up their next big investment. Enter Hilton Head, S.C., a place where strategic move means scooping up properties that marry lifestyle with fiscal savvy. Sizing Up the Dream: More Than Just...

Continue Reading
Soleno Therapeutics Faces Shareholder Legal Scrutiny

Updated Category News Views 0

Legal Storm Brews for Soleno's Execs When you see Kuehn Law stepping into the ring, you know someone’s ruffling feathers. And this time, the target is Soleno Therapeutics (NASDAQ:SLNO), a name that might ring bells for tech folks dabbling in biotech. They’re under the spotlight because a federal securities lawsuit claims a questionable playbook was in the shuffle....

Continue Reading
Hycroft Overhauls Board with Mining Heavyweights

Updated Category News Views 2

High-Caliber Recruits Steer Hycroft's Ambitious Path Hycroft Mining's move to bulk up its board ought to raise eyebrows across the mining landscape. By snagging some of the biggest names in the industry, they're not just shuffling the deck—they're bringing in a whole new game plan. If you're tracking NASDAQ:HYMC, this is news you don't brush off. The New Power Quartet...

Continue Reading

Top 5 Most Recently Viewed Articles

Join the Class Action Suit Against Inspire Medical Systems

Updated Category News Views 103

Class Action Notice for Inspire Medical Systems, Inc. Attention shareholders! The Gross Law Firm has issued an important message concerning Inspire Medical Systems, Inc. (NYSE: INSP). This notice is particularly relevant for those who purchased shares within the designated class action period. If you are an investor in INSP, it is vital to understand the implications of...

Continue Reading
Illumina's Q3 2025 Financial Highlights Demonstrate Stability

Updated Category News Views 294

Illumina's Financial Results Overview Illumina, Inc. (Nasdaq: ILMN) has recently presented its financial results for the third quarter of fiscal year 2025. The company reported a revenue of $1.08 billion, indicating stability as it remained flat compared to the same quarter in the previous year, both on a reported and constant currency basis. Notably, the GAAP diluted...

Continue Reading
Azitra's Strategy to Transform Skin Disease Treatments

Updated Category News Views 187

Azitra's Upcoming Presentation at Prominent Forum Azitra, Inc. (NYSE American: AZTR), a biopharmaceutical company dedicated to precision dermatology, is set to have its Chief Operating Officer, Travis Whitfill, Ph.D., MPH, present groundbreaking research at the Microbiome Times Partnering Forum. This esteemed event, known for attracting key industry players, will take...

Continue Reading
Safe Pro Group Secures Provisional Patent for AI Drone Tech

Updated Category News Views 154

Safe Pro Group Advances with New Provisional Patent Safe Pro Group Inc. (Nasdaq: SPAI) is on the cutting edge of innovation with a recent provisional patent application filed for leveraging drones and artificial intelligence (AI) in enhancing object detection precision. This comes as a significant step for the company, dedicated to providing high-quality AI solutions,...

Continue Reading
MoneyGram Ramps: Connecting Cash and Crypto Effortlessly

Updated Category News Views 242

Revolutionizing Cash and Crypto Transactions MoneyGram has announced a powerful new tool, MoneyGram Ramps, designed specifically for developers looking to connect cash and cryptocurrency seamlessly. This innovative API allows for quick and compliant cash-to-crypto and crypto-to-cash integrations, changing the way digital financial transactions occur worldwide. The Easiest...

Continue Reading